819 Radiomic markers associated with clinical benefit in advanced uveal melanoma patients with radiographic progression on tebentafusp

Beylergil, V., Collins, L., Schwartz, L., Eche, T., Zhao, B., Carvajal, R., Abdullah, S., Beylergil, V., & Dercle, L. (2021). 819 Radiomic markers associated with clinical benefit in advanced uveal melanoma patients with radiographic progression on tebentafusp. Regular and Young Investigator Award Abstracts, A857–A857. https://doi.org/10.1136/jitc-2021-sitc2021.819
Authors:
Volkan Beylergil
Laura Collins
Lawrence H. Schwartz
Thomas Eche
Binsheng Zhao
Richard D. Carvajal
Shaad E. Abdullah
Volkan Beylergil
Laurent Dercle
Affiliated Authors:
Volkan Beylergil
Lawrence H. Schwartz
Thomas Eche
Binsheng Zhao
Richard D. Carvajal
Volkan Beylergil
Laurent Dercle
Columbia Affiliation:
Subjects:
Ocular Cancer Research and Treatment (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Nanotechnology and Imaging for Cancer Therapy and Diagnosis (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2021-sitc2021.819
DOI:
10.1136/jitc-2021-sitc2021.819
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: